# Program 6: Lymphoma and Myeloma

> **NIH NIH P30** · DANA-FARBER CANCER INST · 2021 · $73,736

## Abstract

Lymphoma and Myeloma Program 
Project Summary / Abstract 
The Lymphoma and Myeloma Program explores the causes, define the pathogenetic mechanisms, and 
improve the therapy of lymphoid neoplasms. Program members are: 1) experts in many of the most common 
lymphoid malignancies; 2) investigators with lymphoma and myeloma research programs spanning basic, 
translational and clinical areas; 3) dedicated clinical investigators; 4) hematopathologists with demonstrated 
expertise in lymphoid malignancies; and 5) computational biologists and biostatisticians with a focus on these 
diseases. Program Specific Aims are to: 1) Elucidate pathogenetic mechanisms underlying specific lymphoid 
neoplasms; 2) Develop novel therapeutic approaches to lymphoid malignancies; 3) Evaluate treatment 
outcomes and long-term complications in lymphoma and myeloma patients. The program has 74 members, 
representing five DF/HCC institutions and 12 academic departments. In 2014 peer-reviewed grant funding 
attributed to the Program was $10.1 million in total costs from the NCI and $8.2 million from other sponsors. 
During the current funding period, Lymphoma & Myeloma Program members published 1,271 cancer-relevant 
papers. Of these 30% were inter-institutional, 26% were intra-programmatic, and 44% were inter-programmatic 
collaborations between two or more DF/HCC members. Overall, when counted once, 27% of DF/HCC 
publications were inter-programmatic collaborations.

## Key facts

- **NIH application ID:** 10062921
- **Project number:** 5P30CA006516-56
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** Irene M. Ghobrial
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $73,736
- **Award type:** 5
- **Project period:** 1997-03-10 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10062921

## Citation

> US National Institutes of Health, RePORTER application 10062921, Program 6: Lymphoma and Myeloma (5P30CA006516-56). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10062921. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*